Skip to main content
David Telander, MD, Ophthalmology, Sacramento, CA

David G. Telander MD PhD

Retinal Disease


Retinal Consultants of Sacramento; Clinical Professor at UC Davis

Join to View Full Profile
  • 3939 J StSte 106Sacramento, CA 95819

  • Phone+1 916-454-4861

  • Fax+1 916-454-3603

Dr. Telander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Surgical Retina and Vitreous, 2003 - 2005
  • University of Minnesota
    University of MinnesotaResidency, Ophthalmology, 2000 - 2003
  • Hennepin Healthcare
    Hennepin HealthcareInternship, Transitional Year, 1999 - 2000
  • Stanford University
    Stanford UniversityBAS, Biology and History, 1986 - 2000
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2026
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • Super Doctor SuperDoctors.com
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Clinical Trial in Dry-AMD with the Opening of Two Additional U.S. Sites
    Clinical Trial in Dry-AMD with the Opening of Two Additional U.S. SitesMay 24th, 2018
  • Dr. David Telander Named Among the Top 1% of Doctors in the Nation
    Dr. David Telander Named Among the Top 1% of Doctors in the NationMarch 10th, 2016

Grant Support

  • Novel Therapies To Prevent Blindness Caused By Proliferative VitreoretinopathyNational Eye Institute2010–2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: